Pacer Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Sell |
20,393
-10,427
| -34% | -$5.66M | 0.03% | 445 |
|
|
2025
Q4 | $17.9M | Sell |
30,820
-564
| -2% | -$319K | 0.05% | 344 |
|
|
2025
Q3 | $15.2M | Sell |
31,384
-492
| -2% | -$229K | 0.04% | 385 |
|
|
2025
Q2 | $12.9M | Buy |
31,876
+11,492
| +56% | +$4.8M | 0.03% | 416 |
|
|
2025
Q1 | $10.1M | Sell |
20,384
-11,175
| -35% | -$6.05M | 0.02% | 472 |
|
|
2024
Q4 | $16.4M | Buy |
31,559
+2,642
| +9% | +$1.45M | 0.04% | 370 |
|
|
2024
Q3 | $17.9M | Buy |
28,917
+17
| +0.1% | +$10.1K | 0.04% | 353 |
|
|
2024
Q2 | $16M | Buy |
28,900
+1,685
| +6% | +$965K | 0.04% | 361 |
|
|
2024
Q1 | $15.8M | Buy |
27,215
+1,756
| +7% | +$985K | 0.04% | 353 |
|
|
2023
Q4 | $13.5M | Sell |
25,459
-237
| -0.9% | -$115K | 0.04% | 350 |
|
|
2023
Q3 | $13M | Buy |
25,696
+470
| +2% | +$250K | 0.05% | 286 |
|
|
2023
Q2 | $13.2M | Buy |
25,226
+927
| +4% | +$500K | 0.05% | 310 |
|
|
2023
Q1 | $14M | Buy |
24,299
+22,391
| +1,174% | +$12.6M | 0.06% | 311 |
|
|
2022
Q4 | $1.05M | Sell |
1,908
-479
| -20% | -$254K | 0.01% | 807 |
|
|
2022
Q3 | $1.21M | Buy |
2,387
+49
| +2% | +$27.4K | 0.01% | 491 |
|
|
2022
Q2 | $1.27M | Sell |
2,338
-18,544
| -89% | -$10.2M | 0.01% | 504 |
|
|
2022
Q1 | $12.3M | Sell |
20,882
-227
| -1% | -$130K | 0.1% | 202 |
|
|
2021
Q4 | $14.1M | Sell |
21,109
-1,637
| -7% | -$1.02M | 0.14% | 125 |
|
|
2021
Q3 | $13M | Sell |
22,746
-28
| -0.1% | -$15.4K | 0.16% | 94 |
|
|
2021
Q2 | $11.5M | Buy |
22,774
+158
| +0.7% | +$74.5K | 0.16% | 100 |
|
|
2021
Q1 | $10.3M | Sell |
22,616
-2,400
| -10% | -$1.15M | 0.18% | 79 |
|
|
2020
Q4 | $11.7M | Sell |
25,016
-4,970
| -17% | -$2.33M | 0.22% | 69 |
|
|
2020
Q3 | $13.2M | Sell |
29,986
-4,902
| -14% | -$2.03M | 0.28% | 63 |
|
|
2020
Q2 | $12.6M | Buy |
34,888
+34,851
| +94,192% | +$11.7M | 0.26% | 70 |
|
|
2020
Q1 | $12K | Sell |
37
-46,301
| -100% | -$14.6M | ﹤0.01% | 614 |
|
|
2019
Q4 | $15.1M | Buy |
46,338
+2,346
| +5% | +$711K | 0.68% | 18 |
|
|
2019
Q3 | $12.8M | Buy |
43,992
+5,087
| +13% | +$1.46M | 0.29% | 61 |
|
|
2019
Q2 | $11.4M | Buy |
38,905
+2,902
| +8% | +$799K | 0.28% | 65 |
|
|
2019
Q1 | $9.85M | Buy |
36,003
+35,911
| +39,034% | +$8.94M | 0.27% | 66 |
|
|
2018
Q4 | $21K | Sell |
92
-21,674
| -100% | -$5.09M | ﹤0.01% | 379 |
|
|
2018
Q3 | $5.31M | Buy |
21,766
+3,219
| +17% | +$741K | 0.2% | 85 |
|
|
2018
Q2 | $3.84M | Buy |
18,547
+3,100
| +20% | +$658K | 0.17% | 94 |
|
|
2018
Q1 | $3.19M | Buy |
15,447
+1,700
| +12% | +$357K | 0.18% | 97 |
|
|
2017
Q4 | $2.61M | Buy |
13,747
+3,433
| +33% | +$658K | 0.18% | 93 |
|
|
2017
Q3 | $1.95M | Buy |
10,314
+1,247
| +14% | +$226K | 0.17% | 86 |
|
|
2017
Q2 | $1.58M | Buy |
9,067
+696
| +8% | +$117K | 0.16% | 101 |
|
|
2017
Q1 | $1.29M | Buy |
8,371
+501
| +6% | +$76.6K | 0.16% | 94 |
|
|
2016
Q4 | $1.11M | Sell |
7,870
-340
| -4% | -$50.1K | 0.16% | 92 |
|
|
2016
Q3 | $1.31M | Buy |
8,210
+74
| +0.9% | +$11.4K | 0.2% | 68 |
|
|
2016
Q2 | $1.2M | Buy |
8,136
+705
| +9% | +$104K | 0.19% | 79 |
|
|
2016
Q1 | $1.05M | Buy |
7,431
+383
| +5% | +$51.3K | 0.24% | 85 |
|
|
2015
Q4 | $1M | Buy |
+7,048
| New | +$940K | 0.23% | 85 |
|
|
2013
Q4 | $362K | Buy |
+2,887
| New | +$287K | 0.09% | 309 |
|
Other funds holding TMO
VCM
Pacer Advisors's TMO Position: Q1 2026 in Review
Pacer Advisors reduced its Thermo Fisher Scientific (TMO) stake by 34% in Q1 2026, selling an estimated $5.66M and leaving 20,393 shares worth $10M. The position accounts for 0.03% of the portfolio, ranked #445.
Pacer Advisors first reported a position in TMO in Q4 2013 and has held it in 43 quarters since. The position peaked at $17.9M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Pacer Advisors held 20,393 shares of Thermo Fisher Scientific worth $10M as of Q1 2026.
- Pacer Advisors sold 10,427 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.66M.
- Thermo Fisher Scientific made up 0.03% of Pacer Advisors's portfolio in Q1 2026, its #445 holding.
- Pacer Advisors first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 43 quarters since.
- Pacer Advisors's Thermo Fisher Scientific position peaked at $17.9M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.